Previous close | 503.20 |
Open | 505.40 |
Bid | 498.50 x N/A |
Ask | 0.00 x N/A |
Day's range | 499.80 - 505.40 |
52-week range | 374.00 - 506.80 |
Volume | |
Avg. volume | 0 |
Market cap | 117.012B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 20.15 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 6.06 (1.20%) |
Ex-dividend date | 10 Jun 2024 |
1y target est | N/A |
INDIANAPOLIS, May 30, 2024--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the "Investors" link. You may also access the link here.
INDIANAPOLIS, May 20, 2024--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strategic Decisions Conference in New York City, on May 31 at 9:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the "Investors" link. You may also access the link here.
Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the be